Guest guest Posted November 18, 2007 Report Share Posted November 18, 2007 And wait 'til you read the " side effects " . . . (Cancer Decisions News Staff) Ralph W. Moss, Ph.D. Weekly CancerDecisions.com Newsletter #315 11/18/07 THE MOSS REPORTS - CANCER DECISIONS NEWSLETTER Earlier this year, the US Food and Drug Administration (FDA) approved the drug Tykerb (lapatinib) to treat advanced breast cancer. What can breast cancer patients realistically expect from this drug? To read or listen to this week's newsletter, please click here or go to: http://www.cancerdecisions.com/111807.html [and scroll down to bottom of page] Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.